City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					             City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH189950D                                                                                                              Publication Date: APR 2013

      Company Overview                                                                                         Key Facts
      City of Hope (COH) is a biomedical research company, based in the US. The
                                                                                                               City of Hope, Pharmaceuticals & Healthcare, Key
      company provides treatment services for a wide range of cancers, diabetes and
                                                                                                               Facts
      infectious diseases. Its patient care services include treatment and services, patient
      and visitor guide, interpreter services, medical facilities, clinical trials and patient and              Web Address                           www.cityofhope.org
      community education. COH focuses on innovative research to translate discoveries
                                                                                                                Revenue (US$ million)                                NA
      into life saving treatments for cancer fighting drugs, herceptin, rituxan and avastin.
      The company’s educational services are for post-doctoral fellowships through its                          Number of Employees                                  NA
      affiliate Irell & Manella Graduate School of Biological Sciences.                                         GlobalData

      Financial Deals Landscape
        City of Hope, Pharmaceuticals & Healthcare, Deals by Type, 2007                    City of Hope, Pharmaceuticals & Healthcare, Deals By Year,
        to YTD 2013                                                                        2007 to YTD 2013


                                                                                                                            3      3
                                                                                                           3




                                                                                            No. of Deals
                                                                                                           2

                                                                                                                                            1
                                                                                                           1

                                                                                                                  0                                   0    0          0
                                                                                                           0
                                                                                                                2007       2008   2009     2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                           Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                           from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         City of Hope, Pharmaceuticals & Healthcare, Deals By                              City of Hope, Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                          Therapy Area, 2007 to YTD 2013

                         8     7
                                                                                                                       3
          No. of Deals




                         6                                                                                 3
                                                                                            No. of Deals




                         4                                                                                                             2
                                                                                                           2
                         2              1         1        1         1

                         0                                                                                 1
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and                                                                            0              0
                               a                          and     Central                                  0
                                                         Africa   Americ                                          Infectiou Oncology Cardiova              Central
                                                                    a                                             s Disease           scular               Nervous
                                                                                                                                                           System


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                     Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                           from 2006 onwards, GlobalData




City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                 Reference Code: GDPH189950D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .............................................................................. 4
       City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .............................................................................. 5
       City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .......................................................................... 6
       City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................................ 7
       City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................................... 8
       City of Hope, Pharmaceuticals & Healthcare, Deal Details ................................................................................................................ 9
          Partnerships.................................................................................................................................................................................... 9
             Affomix Enters Into Agreement With City of Hope ....................................................................................................................... 9
             Advaxis Enters Into Co-Development Agreement With City Of Hope........................................................................................ 10
             DxTerity Diagnostics Enters Into Co-Development Agreement With City Of Hope ................................................................... 11
             Advaxis Enters Into Collaboration With City of Hope................................................................................................................. 12
          Licensing Agreements .................................................................................................................................................................. 13
             Benitec Obtains Rights To T cell HIV Therapeutic .................................................................................................................... 13
             Active Motif Enters Into Licensing Agreement With City of Hope .............................................................................................. 14
             Benitec Enters Into Licensing Agreement With City of Hope..................................................................................................... 15
       City of Hope - Key Competitors ........................................................................................................................................................ 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
          Other Locations & Subsidiaries ..................................................................................................................................................... 18
       Recent Developments ...................................................................................................................................................................... 19
          Legal and Regulatory ...........................................................................................
				
DOCUMENT INFO
Description: City of Hope (COH) is a biomedical research company, based in the US. The company provides treatment services for a wide range of cancers, diabetes and infectious diseases. Its patient care services include treatment and services, patient and visitor guide, interpreter services, medical facilities, clinical trials and patient and community education. COH focuses on innovative research to translate discoveries into life saving treatments for cancer fighting drugs, herceptin, rituxan and avastin. The company’s educational services are for post-doctoral fellowships through its affiliate Irell & Manella Graduate School of Biological Sciences. It has many collaborations with clinical, research, fundraising and educational institute. COH is headquartered in Duarte, California, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.